Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection.
about
The stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein.Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challengeCD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment.Respiratory syncytial virus vaccinesInnate immune recognition of respiratory syncytial virus infection.Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodiesAntibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in miceNeed for a safe vaccine against respiratory syncytial virus infection.Detection, pathogenesis, and therapy of respiratory syncytial virus infectionsBovine respiratory syncytial virus protects cotton rats against human respiratory syncytial virus infection.Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus.Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived.Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells.Conformational studies of a short linear peptide corresponding to a major conserved neutralizing epitope of human respiratory syncytial virus fusion glycoprotein.Respiratory syncytial virus infection: from biology to therapy: a perspective.Mapping an antibody-binding site and a T-cell-stimulating site on the 1A protein of respiratory syncytial virusRole of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response.Targeting RSV with vaccines and small molecule drugs.Immunity to human and bovine respiratory syncytial virus.Nosocomial viral infections: recent developments and new strategies.Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.Baculovirus expression of the fusion protein gene of bovine respiratory syncytial virus and utility of the recombinant protein in a diagnostic enzyme immunoassay.Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection.Biochemical characterizations of two temperature-sensitive and attenuated strains of respiratory syncytial virus subgroup B.Detection of antibodies to respiratory syncytial virus attachment and nucleocapsid proteins with recombinant baculovirus-expressed antigensEvolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein.Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies.Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles.Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes.Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies.Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies.Immunofluorescence assay for detection of human metapneumovirus-specific antibodies by use of baculovirus-expressed fusion protein.Frame shift mutations as a novel mechanism for the generation of neutralization resistant mutants of human respiratory syncytial virus.Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults.The therapeutic potential of monoclonal antibodies against respiratory syncytial virus.Prevalence of anti-human respiratory syncytial virus antibodies over three consecutive years in a healthy adult population.Antibody responses of children to the C-terminal peptide of the SH protein of respiratory syncytial virus and the immunological characterization of this protein.Immunoglobulin-class-specific immune response to respiratory syncytial virus structural proteins in infants, children, and adults.
P2860
Q30440686-D9CE0B56-5381-491A-8237-193793CD291AQ33783066-3B456ECD-851B-4513-987B-7245ABA49F6FQ33801890-E5419A9B-372D-4D4E-BC20-BBC35BAEE85CQ33975330-0469290A-BF9B-4C5A-BC7F-6BFC27274F02Q34180049-BEE280DB-9C2F-4188-B591-C7EB6D604558Q34307704-6857EBE5-2E17-4F42-AA96-81731CC9D808Q34425648-B42B94D8-B339-406F-B8D1-85DAB8891A6FQ36106575-000BFA87-E930-44A6-BC0E-6F3A8EE8055AQ36266896-3508761A-8FCA-4D45-9B7B-6F4C7B208259Q36632499-03EF46C0-16B9-4130-9216-02F708C780B3Q36643763-01A4D220-7C46-4DEB-A9AF-6FB3665E89FBQ36679855-ED379E5E-A0A1-4446-BCF5-AF5D7F706382Q36683018-18A8B288-0BFC-4A80-B4E1-ED0003504FC6Q36797478-970707D6-D8AB-4794-9B81-10BCD03A4C1BQ36823304-B1A73A03-D957-4043-A1FC-A39D3B23F906Q36834294-A4C5FBBF-3704-4AC9-ACFE-8383110177B7Q36873331-0217B691-4F69-49F5-81BA-2692BB476B1DQ36875715-BC1D639F-2013-41C5-9909-D7CC883C3143Q37328584-9565949C-7A2E-4B88-B928-6C0EC9A290A7Q37940915-EC6D01FD-2AF8-40BE-A0B0-8B208583F825Q38222773-8E9E6ECA-191A-41C9-BDC5-1E71AF30F2CBQ38750689-8C1722E0-A0D6-4D85-A764-6C15014F50CBQ39553080-0D8C7B2B-F415-44A7-9C50-ABF20CAAAE9DQ39695161-424A5910-E7DF-4DC3-B599-FD49104AD775Q39870704-3C026659-9E20-4B9A-A3B9-925C89CB7789Q39880109-FA2E33B0-2953-449D-B6F6-5644A083FB80Q40012955-139BEACC-C391-49B1-B161-FA7EC9107838Q40041314-AEDAF079-08E5-4C7E-A99C-4D1AA0BA7A8BQ40065065-AF0633F7-2593-47E9-B8C4-3FE7EF8654FEQ40065136-FE283D27-516D-4076-BBAE-1B92FC76A89EQ40067229-79E0DD85-FC73-4892-A662-26C00D42CB1FQ40101115-2ED57BED-1094-4A37-A985-00AC28F48939Q40130924-5174D72A-545D-4C8B-A167-6AB9E4280204Q40772847-09115FA6-C14B-414C-BCB7-1F92DEC3BBD1Q41235315-E38D6092-DF7A-476F-8B87-410A6E40736AQ43979004-23DA8898-79FC-4F1A-8DE0-72550F1B3973Q45439981-67EB3A8F-EDBD-4EAB-8FFC-C6BB62CCE38EQ45722102-EA4A36BB-9E96-42BD-9FE7-13F0EB401701Q45776082-86B8C4E7-02EC-4ACD-883F-68997F7B57BDQ45843538-D3C14970-B958-4BF3-B240-2388CB158124
P2860
Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Immunization with glycoprotein ...... rats against viral infection.
@en
Immunization with glycoprotein ...... rats against viral infection.
@nl
type
label
Immunization with glycoprotein ...... rats against viral infection.
@en
Immunization with glycoprotein ...... rats against viral infection.
@nl
prefLabel
Immunization with glycoprotein ...... rats against viral infection.
@en
Immunization with glycoprotein ...... rats against viral infection.
@nl
P2093
P356
P1476
Immunization with glycoprotein ...... rats against viral infection.
@en
P2093
P304
P356
10.1093/INFDIS/155.6.1198
P407
P577
1987-06-01T00:00:00Z